Fall Savings30% off everything · Code:
Back
Endocrine / Growth Research

Tesamorelin / Ipamorelin

VSC-TIP15Research Use Only

A two-peptide research combination pairing Tesamorelin (a GHRH analog) and Ipamorelin (a selective GH secretagogue), studied for their roles in GH/IGF-1 axis signaling. For laboratory research use only.

$130$91WITH CODE FALL
Dosage
Quantity
$130.00
Bundle & save
Free priority shipping on $250+
Third-party tested
U.S.-synthesized & shipped
Discreet packaging
Secure checkoutVisaMastercardAmerican ExpressDiscover

Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.

Compound Information

Technical specifications

Molecular Profile

What is this compound?

This is a two-compound research combination of Tesamorelin, a stabilized growth hormone releasing factor (GHRH) analog, and Ipamorelin, a selective pentapeptide growth hormone secretagogue, both supplied as a lyophilized powder for in vitro laboratory research use only. Both are independently characterized in the peer-reviewed literature: Tesamorelin as a GHRF analog studied in visceral adipose-tissue research, and Ipamorelin as the first selective growth hormone secretagogue described in the literature.

Research applications: Commonly used in GHRH receptor signaling studies, growth hormone secretagogue research, and GH/IGF-1 axis research applications.

Type
Two-peptide research combination (Tesamorelin, Ipamorelin)
Sequence
Combination of two distinct research peptides; see individual compound records
Storage Requirements

Stability Information

Protect from lightTemperature-sensitive
Lyophilized (powder)-20°C · stable long-term
Reconstituted2-8°C · use within 28 days

Sources & References

Peer-reviewed research

The Journal of Clinical Endocrinology and Metabolism
2010PMID 20554713DOI 10.1210/jc.2010-0490
Falutz J, Mamputu JC, Potvin D, et al.
View on PubMed
The Annals of Pharmacotherapy
2012PMID 22298602DOI 10.1345/aph.1Q629
Spooner LM, Olin JL
View on PubMed
European Journal of Endocrinology
Ipamorelin, the first selective growth hormone secretagogue
1998PMID 9849822DOI 10.1530/eje.0.1390552
Raun K, Hansen BS, Johansen NL, et al.
View on PubMed

Some titles are not reproduced here. Ventra Sciences sells for research use only and does not republish therapeutic indications; open the record on PubMed to read the full citation.

References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.

For research use only

This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.

By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.

Subscribe to our newsletter

Exclusive updates and restock alerts, straight to your inbox.